Loading insider details...
Beta
Latest Form 4 (Dec 15, 2025): Grant/Award of 20,000 VYNE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 15, 2025 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 20,000 | n/a |
| Dec 13, 2024 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 20,000 | n/a |
| Aug 26, 2024 | AGILE THERAPEUTICS INC (AGRX) | Disposition to Issuer | 973 | $1.5K |
| Jan 3, 2024 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 20,000 | n/a |
| Dec 15, 2023 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 20,000 | n/a |
| Aug 12, 2022 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 20,500 | n/a |
| Jul 20, 2021 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 20,500 | n/a |
| Aug 21, 2020 | Menlo Therapeutics Inc. (MNLO) | Exercise/Conversion | 75,000 | $111.0K |
| Aug 5, 2020 | Menlo Therapeutics Inc. (MNLO) | Grant/Award | 22,500 | n/a |
| Mar 23, 2020 | Menlo Therapeutics Inc. (MNLO) | Grant/Award | 45,000 | n/a |